Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics

An In Vitro Comparative Immunogenicity Assessment (IVCIA) assay was evaluated as a tool for predicting the potential relative immunogenicity of biotherapeutic attributes. Peripheral blood mononuclear cells from up to 50 healthy naïve human donors were monitored up to 8 days for T-cell proliferation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Joubert, Marisa K., Deshpande, Meghana, Yang, Jane, Reynolds, Helen, Bryson, Christine, Fogg, Mark, Baker, Matthew P., Herskovitz, Jonathan, Goletz, Theresa J., Zhou, Lei, Moxness, Michael, Flynn, Gregory C., Narhi, Linda O., Jawa, Vibha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975389/
https://www.ncbi.nlm.nih.gov/pubmed/27494246
http://dx.doi.org/10.1371/journal.pone.0159328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975389/
https://www.ncbi.nlm.nih.gov/pubmed/27494246
http://dx.doi.org/10.1371/journal.pone.0159328

Ejemplares similares